Clinical Trial

Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL

Name: Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL — clinical trial record (NCT06289959)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A prospective, single center, randomized, clinical controlled study to evaluate the efficacy and prognosis differences between precision treatment based on plasma cfDNA testing results and the current conventional diagnostic and treatment practices for DLBCL patients.

Trial Details

NCT Number	NCT06289959
Lead Sponsor	Second Affiliated Hospital of Soochow University
Conditions	Lymphoma, Large B-Cell, Diffuse
Enrollment	30 participants
Start Date	2024-02-25
Primary Completion	2029-01-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2024-03-04